Home
The 2010 Executive Pay in the Biopharmaceutical Industry Report is immediately available - click here to learn more!
The 2010 Executive Pay in the Medical Device Industry Report is immediately available- click here to learn more!
Top 5 Data Services offers in-depth compensation consulting and research services primarliy for life sciences companies
Since 1994, Top 5 has produced concise, easy-to-use annual reports on executive pay in publicly traded companies that are widely recognized as best in class. Our current reports include:
No participation is required to order either of these two reports. You can have instant access to the data.
These annual reports reflect SEC filings through May 2010. All publicly traded (and many privately-held) companies in the life sciences sector can benefit from these reports, regardless of size or stage of development. All vital pay statistics are summarized by six levels of total employment size and revenue (including pre-revenue companies), making these reports the industry reference benchmark. Click on either report link above to see the data format and the list of companies represented in each.
Top 5 has just published a comprehensive report on Board of Directors pay for the Life Sciences Industry. Our 2010 Board Compensation in the Life Sciences Industry report offers the same depth and ease of use as our highly regarded executive pay reports, and draws from our analysis of recent filings by publicly traded U.S. companies. The study has data from 179 publicly traded medical device and 298 biopharmaceutical companies. The data is broken out by industry sector (device and biopharma) and by market capitalization, ensuring that relevant data is available for all medical device or biopharmaceutical companies, regardless of product mix, size or stage-of-development.
The report is available in Acrobat format, with a complete set of table and graphs, and in an Excel spreadsheet format that allows you to conduct your own analysis of the data. The Excel data sets are available in three versions: covering all medical device companies, all biopharmaceutical companies or a combined set covering all U.S. public life sciences companies.
Click on the highlighted link to learn more about the report and for order information: Go to BOD Report webpage.
